A Real-World Evaluation of the Long-Term Safety and Efficacy of Infliximab in the Treatment Moderate-To-Severe Psoriasis

figure

posted on 2020-08-18, 09:23 authored by Emily K. Haque, Aaminah Azhar, John Corbett, Jillian Frieder, Xuan Wang, Alan Menter

Article full text

The above summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

Usage metrics

Keywords

Antibodies to infliximab Infliximab Long term response Methotrexate Obesity Plaque psoriasis Weight-based dose

Licence

CC BY-NC 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM